4-MeO-PCP (4-Methoxyphencyclidine) is a PCP-related arylcyclohexylamine characterized by a methoxy (-OCH₃) substitution at the 4-position of the phenyl ring. This structural modification makes it relevant for structure–activity relationship (SAR) research, analytical profiling, and comparative dissociative-class studies.
In the EU and Netherlands, 4-MeO-PCP is handled strictly as a laboratory reference material with no approved medical, therapeutic, or commercial applications.
Research & Chemical Summary
| Attribute | Details |
|---|---|
| Common Name | 4-MeO-PCP |
| Chemical Name | 4-Methoxyphencyclidine |
| Chemical Class | Arylcyclohexylamine |
| Research Status | Research Chemical 🧪 |
| Physical Form | Powder |
| Intended Use | Laboratory & analytical research only |
| Region Focus | Europe / Netherlands (EU) |
Scientific & Analytical Context
4-MeO-PCP is typically referenced in research for:
-
Comparative analysis of PCP-class compounds
-
Structure–activity relationship (SAR) evaluation
-
Analytical method development (GC/MS, LC/MS)
-
Forensic and spectral reference applications
Most publicly available information focuses on chemical structure and identification, with limited formal pharmacological or toxicological data.
Chemical Specifications
| Property | Value |
|---|---|
| Molecular Formula | C₁₇H₂₅NO₂ |
| Molecular Weight | ~279.39 g/mol |
| CAS Number | 15679-21-7 |
| IUPAC Name | 1-[1-(4-methoxyphenyl)cyclohexyl]piperidine |
| PubChem CID | 57470699 |
Structural Identifiers
| Identifier | Data |
|---|---|
| SMILES | COc1ccc(cc1)C2(CCCCC2)N3CCCCC3 |
| InChIKey | PBOWKZJJHGXWNI-UHFFFAOYSA-N |
Key Research Characteristics
| Feature | Summary |
|---|---|
| Compound Type | PCP-class analog |
| Structural Interest | Para-methoxy phenyl substitution |
| Research Focus | SAR, analytical & forensic studies |
| Documentation | CAS, molecular & structural data |
Compliance & Handling Notice
This product is supplied exclusively for laboratory and analytical research purposes.
Not intended for human or animal use.
